80% of high-risk prostate cancer patients don't know how to check early prostate cancer
Sep 10, 2024
According to a survey of 1,000 men in their 50s or older in Korea conducted by the Korea Urology Foundation and the Korean Society of Oncology, 8 out of 10 respondents do not know exactly how and how to check for early prostate cancer.
The Korea Urology Foundation and the Korean Society of Urology and Oncology conducted an OX quiz-type survey from August 8 to 9 to find out the level of awareness of prostate cancer among 1,000 men in their 50s and older, who are at high risk for prostate cancer, as part of the Blue Ribbon Campaign to promote prostate cancer awareness to the public. The survey was planned with 19 questions, including ▶ causes and occurrences of prostate cancer ▶ symptoms of prostate cancer ▶ diagnosis of prostate cancer ▶ treatment and prognosis of prostate cancer, and the understanding of early prostate cancer screening methods and cycles was particularly low.
The Prostate Specific Antigen (PSA), a representative prostate cancer screening test, is a test to determine blood PSA levels through a simple blood test. However, 71.9% of the respondents mistook the PSA test for a urine test. In addition, although the PSA test is not a test to confirm prostate cancer, 69.0% of the respondents misunderstood it as a confirmatory test, indicating that recognition needs to be corrected.
In addition, about 8 out of 10 respondents (79.7%) did not know the exact test cycle for early detection of prostate cancer. Prostate cancer, in particular, has a higher survival rate as it is diagnosed and treated early. According to national cancer registration statistics released in 2023, the five-year relative survival rate of all prostate cancers is high at 96.0%, but if the cancer crosses the prostate and develops distant metastasis, the five-year relative survival rate is significantly reduced to about 48.8%. Since prostate cancer is a cancer with a high survival rate if it is detected early, men over the age of 50 should be screened for prostate cancer through regular PSA tests every year.
On the other hand, 69.0% of the respondents misunderstood the cause of prostate cancer as a disease caused by neglecting prostate hypertrophy. In addition, 88.9% (n=889/1,000) of respondents misunderstood the initial symptoms of prostate cancer as 'dysuria', even though prostate cancer often shows few symptoms in the early stages and is often detected during medical examinations. Urination disorders such as dysuria, frequent urination, night urination, urination, and hematuria, which are easy to misunderstand as early symptoms of prostate cancer, appear when the cancer is significantly advanced, so men over 50 should undergo PSA tests regularly even if they do not have symptoms.
Kim Sun-il, chairman of the Korean Society of Oncology and Oncology (Aju University Hospital's urology department), emphasized that "prostate cancer is often diagnosed late because there are no noticeable symptoms in the early stages." "Since prostate cancer is less interested than other carcinomas because it is recognized as a mild cancer, prostate cancer is also difficult to treat and the survival rate is greatly reduced by less than half when it metastasizes to other organs. Therefore, men in their 50s or older should undergo PSA tests once a year at a nearby urology department even if they do not have symptoms for early detection of prostate cancer."
The Korea Urology Foundation and the Korean Society of Urology and Oncology conducted an OX quiz-type survey from August 8 to 9 to find out the level of awareness of prostate cancer among 1,000 men in their 50s and older, who are at high risk for prostate cancer, as part of the Blue Ribbon Campaign to promote prostate cancer awareness to the public. The survey was planned with 19 questions, including ▶ causes and occurrences of prostate cancer ▶ symptoms of prostate cancer ▶ diagnosis of prostate cancer ▶ treatment and prognosis of prostate cancer, and the understanding of early prostate cancer screening methods and cycles was particularly low.
The Prostate Specific Antigen (PSA), a representative prostate cancer screening test, is a test to determine blood PSA levels through a simple blood test. However, 71.9% of the respondents mistook the PSA test for a urine test. In addition, although the PSA test is not a test to confirm prostate cancer, 69.0% of the respondents misunderstood it as a confirmatory test, indicating that recognition needs to be corrected.
In addition, about 8 out of 10 respondents (79.7%) did not know the exact test cycle for early detection of prostate cancer. Prostate cancer, in particular, has a higher survival rate as it is diagnosed and treated early. According to national cancer registration statistics released in 2023, the five-year relative survival rate of all prostate cancers is high at 96.0%, but if the cancer crosses the prostate and develops distant metastasis, the five-year relative survival rate is significantly reduced to about 48.8%. Since prostate cancer is a cancer with a high survival rate if it is detected early, men over the age of 50 should be screened for prostate cancer through regular PSA tests every year.
On the other hand, 69.0% of the respondents misunderstood the cause of prostate cancer as a disease caused by neglecting prostate hypertrophy. In addition, 88.9% (n=889/1,000) of respondents misunderstood the initial symptoms of prostate cancer as 'dysuria', even though prostate cancer often shows few symptoms in the early stages and is often detected during medical examinations. Urination disorders such as dysuria, frequent urination, night urination, urination, and hematuria, which are easy to misunderstand as early symptoms of prostate cancer, appear when the cancer is significantly advanced, so men over 50 should undergo PSA tests regularly even if they do not have symptoms.
Kim Sun-il, chairman of the Korean Society of Oncology and Oncology (Aju University Hospital's urology department), emphasized that "prostate cancer is often diagnosed late because there are no noticeable symptoms in the early stages." "Since prostate cancer is less interested than other carcinomas because it is recognized as a mild cancer, prostate cancer is also difficult to treat and the survival rate is greatly reduced by less than half when it metastasizes to other organs. Therefore, men in their 50s or older should undergo PSA tests once a year at a nearby urology department even if they do not have symptoms for early detection of prostate cancer."
|
bellho@sportschosun.com
